IRCT201509213449N19已完成2 期
Comparing efficacy and safety of Meropenem/Ampicillin-sulbactam and Meropenem/Colistin in treatment of ventilator associated pneumonia due to resistant gram negative microorganisms
Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Adult patients (18-65 years old) with ventilator-associated pneumonia due to multidrug resistant gram negative organisms will be included.
- •Exclusion criteria: Infection with gram negative organism with meropenem MIC > 8 µg/ml; Infection with gram negative organism with colistin MIC > 2 µg/ml; Patients with an allergy to each of two antibiotic regimens
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Meropenem fot the treatment of serious bacterial infections in neonates and young infantssuspected or proven late onset neonatal sepsisMedDRA version: 14.1Level: PTClassification code 10040049Term: Sepsis neonatalSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001515-31-LTPENTA Foundation Onlus550
进行中（未招募）
不适用
Meropenem for the treatment of serious bacterial infections in neonatesand young infantssuspected or proven late onset neonatal sepsisMedDRA version: 14.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001515-31-GRPENTA Foundation Onlus550
进行中（未招募）
不适用
Meropenem for the treatment of serious bacterial infections in neonates and infants below 90 days of age inclusiveEUCTR2011-001515-31-EEFONDAZIONE PENTA ONLUS550
进行中（未招募）
不适用
MEROPENEM FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS IN NEONATES AND YOUNG INFANTSSUSPECTED OR PROVEN LATE ONSET NEONATAL SEPSISMedDRA version: 14.1Level: PTClassification code 10053840Term: Bacterial sepsisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001515-31-ESPENTA Foundation Onlus550
已完成
3 期
Effect of nebolized G-CSF in treatment of Ventilator Associated Pneumonia (VAP)IRCT20150824023743N2Esfahan University of Medical Sciences60